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Introduction
Analysis of ST-segment resolution on ECG, after
fibrinolytic therapy, in cases of ST elevation Myocardial
Infarction offers an attractive and cost effective solution to
assess coronary reperfusion. Whereas coronary angiogram
is a marker for epicardial reperfusion, ST segment
resolution offers a better reflection of microvascular
reperfusion. Although successful thrombolysis of the
epicardial vessel is necessary for good prognosis, but the
micro-vascular flow more strongly correlates with the
outcome. ST segment is therefore a better indicator of
prognosis, and provides information, which cannot be
assessed on basis of cardio angiogram alone.1-3 In fact
Schroeder et al4 reported that absence of ST segment
resolution was the most powerful independent predictor of
early mortality (p = 0.0001). ST resolution can also be used
as a tool to identify candidates for early invasive procedures
such as PTCA, who are at risk of developing complications
because of non resolution of ST segment after initial
thrombolytic therapy5 Since ECG is widely available even
in developing nations, it is important to establish its
effectiveness as a tool for assessing reperfusion as it will
offer the cheapest alternative for assessing recovery and
myocardial salvage. The aim of our study was to correlate
the incidence of complications with ST-segment resolution,
thereby re-enforcing the role of ST-resolution as a marker of
improved clinical outcome in cases of ST-elevated
myocardial Infarction in our population.
Patients and Methods
The duration of the prospective study conducted at
Punjab Institute of Cardiology, was 6 months starting from
July 2006 to January 2007. The study included data of 148
diagnosed cases of acute Myocardial Infarction. The
diagnosis was based on WHO criteria for acute myocardial
infarction i.e. presence of any two of the following: 1) Chest
pain consistent with acute myocardial infarction of less than
24hrs duration, 2) Electrocardiography changes i.e. ST-
segment elevation >0.2mv in at least two contiguous chest
leads or >0.1mv in at least two contiguous limb leads, 3)
New or presumably New left bundle branch block on
Electrocardiogram and 4) raised levels of cardiac enzymes
CPK-MB more than double of the reference value or
positive Troponin I test done with commercially available
kits of Trop I. 
Inclusion criterion: only patients with ST elevated
MI who received Streptokinase upon presentation, in
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Abstract
Objective: To compare, the post Myocardial Infarction in-patient outcome of patients with early ST resolution to
those without ST resolution on ECG, in a South Asian population.
Methods: This was a prospective study done at the Punjab Institute of Cardiology, Lahore. Consecutive patients
of ST elevation myocardial infarction, who were not treated with primary angioplasty but were thrombolysed were
recruited at the time of arrival in the emergency department. Streptokinase was administered to all patients as
the agent of thrombolysis. ECG was acquired at baseline and at 60 minutes post streptokinase administration.
Patients were subsequently divided into two groups
(A) Patients with ST segment resolution, after 60 minutes of administration of streptokinase 
(B). Patients without ST segment resolution, after 60 minutes of administration of streptokinase. 
This cohort was followed up through the in hospital stay for major complications which were recurrent ischaemic
chest pain ,heart failure, arrhythmias and death, during the follow up period (Mean stay 3.01± 0.77 days).
Results: A total of 148 patients were included in this prospective study. There were 122 males and 26 females.
In group A complications developed in 33 (35%) out of 95 patients and 43 (81%) out of 53 patients in group B
(p< 0.001). Recurrent chest pain was present in 19 (20%) patients of group A and 31 (59%) patients of group B
(p<0.001).Heart failure was the most common complication observed in both groups, 26 (27%) patients in group
A and 33 (62%) patients in group B (p<0.001).Arrhythmias were more common in group B, with 17 (32%) patients
from group B and 9 (10%) from group A developing this complication (p<0.001).
Conclusions: The extent of ST segment resolution provides useful information about early clinical outcome in
post-myocardial infarction patients (JPMA 58:283;2008).
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emergency were included in the study.
The study population was divided into two groups
1. Patients with ST segment resolution on
Electrocardiogram. (done after 60 minutes of administration
of streptokinase) and 2. Patients without ST segment
resolution on Electrocardiogram (done after 60 minutes of
administration of streptokinase)
A detailed history was taken, particularly of age,
sex, occupation, address, history of smoking, Diabetes
Mellitus, hypertension and family history of ischaemic heart
disease. Complete physical examination of patients was
done upon presentation in Emergency and important
parameters such as pulse and blood pressure were noted.
Patients were followed up daily. Pulse, ECG changes and
complications if any, were monitored till death or discharge
of the patient. The end point was a composite of recurrent
ischaemic chest pain, Heart failure, arrhythmia or death.
Time from onset of chest pain to presentation of
patient in emergency was noted through history of patient.
ECG recordings of patients were taken upon presentation in
Emergency. ST elevation was recorded in millimeters from
the lead in which maximum elevation was observed
Repeat ECG was performed after 60 minutes of
administration of Streptokinase(SK). ST resolution was
observed in the lead with the maximum ST elevation. ST
resolution was defined as a reduction of > 50% ST segment
elevation after thrombolysis. Follow up was conducted for
each patient throughout his or her hospital stay. The major
complications noted were recurrent ischemic chest pain,
heart failure, arrhythmia and death. 
Recurrent ischaemic chest pain was documented
from the history and ECG, Heart failure was assessed on the
basis of clinical examination, chest X-ray,
echocardiography and coronary angiography reports.
Arrhythmia was assessed seen from the continuous bed side
monitoring of ECG. Tachycardia was defined as pulse rate
>100 and bradycardia as<60 per minute. 
All data was analyzed by SPSS (statistical package
for Social Sciences) version 12.0 for windows. Chi- Square
test was used to compare the demographic characteristics
and complications in both groups 0.05% level of
significance were used.
Results
A total of 148 patients were enrolled in the study, of
these 82% were male and 18% were female.  The overall
mean age of the study participants was 54.4 ± 12.7 years.
Table1 shows the demographic characteristics of the study
population at presentation. Mean age in Group A was 53.34
± 13.38 years while in group B was 56.30 ± 11.26 years.
There was no significant difference between the co-
morbidities of the two groups, with Hypertension showing
the most significant trend (p< 0.097). The history of
hypertension and family history of cardiac disease was
more common in group A, while history of Diabetes
Mellitus and hypercholesterolemia was more common in
group B. Smoking was almost equally prevalent in both the
groups.
Of the 148 consecutive patients included in this
prospective study, there were 95 (64%) patients who
showed ST resolution in their post SK ECG taken after 60
minutes (group A)   while 53 (36%) patients showed no ST
resolution (group B). In group A, 33 (35%) patients
developed complications during their follow up in the
hospital. While in group B, 43 (81%) patients developed
complications during their hospital stay. 
Figure shows the time from onset of symptoms to the
administration of streptokinase for thrombolysis(x-axis)
linked to percentage of patients (y-axis) who showed ST
resolution or did not show ST resolution. (Note: categories
in which there were less than 10 patients presenting were
excluded from the graph) 6 patients were thrombolysed 0.5
hr after onset of symptoms. Among these 3 (50%) showed
Table 1. Demographic Data at time of presentation.
Demographic
Characteristics
ST-resolution present
(gp. A) n=95
ST-resolution absent
(gp. B) n=53
Mean Age (st deviation)
Gender                 M
F
Diabetes Mellitus
Hypertension
Hypercholesterolemia
Family History
Smoking
53.34 ±  13.38
76
19
34 (35%)
38 (40%)
18 (19%)
22 (23%)
48 (51%)
56.30 ± 11.26
46
7
22 (42%)
14 (26%)
12 (23%)
9 (17%)
29 (54%)
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Figure. Time between onset of symptoms and thrombolysis linked to st resolution.
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ST resolution while 3 (50%) showed no ST resolution.
Fifteen patients were administered streptokinase within 1
hour after onset of symptoms, 14 (93%) of them showed ST
resolution while 1 (7%) did not show ST resolution. Among
the 43 patients who were thrombolysed 2 hours after onset
of symptoms, 31 (72%) showed ST resolution and 12 (28%)
did not show ST resolution. Twenty six patients were
thrombolysed 3 hrs after onset of symptoms and among
them 16 (62%) showed ST resolution and 10 (38%)did not
show ST resolution. Two patients received thrombolysis
after 4 hrs of onset of symptoms and in both (100%) cases
ST resolution was absent. Of the 45 patients who were given
streptokinase 6 hrs after onset of symptoms, 26 (58%) of
them showed ST resolution while 19 (42%) did not show ST
resolution. Thrombolysis 12 hours after onset of symptoms
was given to 11 patients. Of these 5 (45%) had ST
resolution while 6 (55%) had no ST resolution in their post
SK ECG.
The most common complications were recurrent
ischaemic chest pain, Heart failure and arrhythmias. Table 2
shows the relationship between these complications and
presence or absence of ST resolution. There was a
statistically significant difference in the incidence of all the
complications between the two groups as shown by the p-
values in Table2. Out of 148 patients, 3 died and their ECG
did not show ST resolution in the post SK ECG.
Mean hospital stay was 3.21± 0.97 days for patients
who showed no ST resolution and 2.89 ± 0.61 days for
patients who showed ST resolution (p<0.001).
Discussion
ST- segment elevated Myocardial infarction
(STEMI) is a serious condition with a bad outcome and
historically ST resolution has been one of the markers used
to assess reperfusion in STEMI. Its importance cannot be
denied as a prognostic indicator and the results of our study
also reinforce this fact. However its use as a cost effective
marker has been underutilized. Our results showed the
incidence of complications, in patients who showed ST
resolution one hour after administration of streptokinase, to
be 35% while the incidence of complications in patients
without ST resolution in their post SK ECG was 81%
(p<0.001), the rate in the latter being substantially higher.
This finding therefore establishes a direct correlation
between ST resolution and the frequency of complications. 
These results are supported by the study carried out
by Bhatia et al.6 Their results showed that the patients who
did not show ST resolution developed complications during
their stay at the hospital more frequently than those who
showed ST resolution. Of the patients who showed ST
resolution, 38% developed complications compared to 83%
of the patients from the non - ST resolution group
(P<0.001). Another study carried out by Aderson RD et al7
showed that presence or absence of ST resolution after
thromobolysis therapy is a useful predictor of mortality in
post myocardial infarction patients. Thus the above-
mentioned references explain that ST-segment resolution is
a useful prognostic indicator and should be used to assess
the efficacy of thrombolysis.
In our study we noted that only 19 (20%) patients
from ST resolution group developed recurrent chest pain
while 31 (59%) from non-ST resolution group developed
recurrent chest pain in their early clinical outcome
(p<0.001). Study conducted by Ioannis vogiatzis et al8
supports our results. Their results showed that recurrent
ischemic angina was observed in 4.21% of the patients who
showed no ST resolution while 3.08 % of the patients who
showed ST resolution experienced recurrent ischemic chest
pain.
In our results we observed that the incidence of
Heart failure was 27% in patients with ST resolution and
62% in patients without ST resolution (p<0.001), during
follow up. Heart failure is the major determinant for
prognosis after myocardial infarction and the most common
complication observed in this study. Our results are
supported by the findings of a study done by the Shlomi
Matetzky et al.9 They report 28% left ventricular
dysfunction rate in patients without ST resolution vs. 19%
in with ST resolution. Another study conducted by
Tomaszuk-Kazberuk A et al10 also supports our results.
Their results showed that frequency of Left Ventricular
dysfunction was greater in post MI patients who did not
show any ST resolution. They concluded that return of
normal LV systolic function is linked to ST resolution. Lee
SG et al11, carried out a study to emphasize the relation
between ST resolution and left ventricular recovery. Their
results showed that in patients with ST segment resolution
left ventricular ejection fraction and muscle contractility
improved significantly. While in patients who did not show
any ST resolution, changes relating to LV function were
insignificant thus there was no improvement in LV function.
They concluded that ST segment resolution is linked to
return of normal LV systolic function and prognosis.
Table 2. Complications in the two groups.
Complication
ST resolution
present (n=95)
ST resolution
absent (n=53)
P value
Recurrent ischemic 
chest pain
Heart failure
Arrhythmia
Death
19 (20%)
26 (27%)
9 (10%)
0 (0%)
31 (59%)
33 (62%)
17 (32%)
3 (6%)
<0.001
<0.001
<0.001
<0.001
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However we assessed clinical heart failure due to the fact
that not every patient was subjected to echocardiography
during hospital stay, but Bainey KR et al12 found that 70%
or higher ST-segment resolution was associated with a
significantly lower incidence of in hospital congestive heart
failure (CHF) and CHF/death.
We observed arrhythmias in 32% of the patients who
had no ST resolution whereas 10% experienced arrhythmias
in the ST resolution group. The results clearly show that
arrhythmias are less frequent in patients who show ST
resolution in their post SK ECG. A study was carried out by
Ioannis vogiatzis et al8 which supports these results. Their
result indicated that arrhythmia was detected in 2.1 %
patients who showed persistent ST elevation in their post
SK ECG while only 1.54% of the patients who showed ST
resolution developed arrhythmia.
The prognosis after ST elevation acute Myocardial
Infarction is affected by various factors such as age, gender,
number of coronary risk factors presented by the patient,
use of aspirin within 7 days, and number of angina attacks
the patients' suffered.13 We could not assess these factors,
which could correlate strongly with mortality in our study.
This was an important limitation. A multi-variant analysis is
required to exclude the importance of these confounding
factors. Another limiting factor was the non-randomized
nature of the research and small size of patients included in
the study. In addition to this it was also limited by the fact
that it was a single centre study and the researchers lacked
experience. .
Conclusion
The findings of our study support the evidence that
ST resolution is a useful and dependable marker for
evaluating micro-vascular perfusion, which in turn
establishes the role of ST resolution as a tool for predicting
prognosis and mortality.
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